Palantir · Anthropic · Taiwan · India · Donald Trump · AMD · CNBC Technology
Barclays cut its 12-month price target to $1,950 from $2,400 while keeping an overweight rating, according to FactSet
Compiled by KHAO Editorial — aggregated from 1 outlet. See llms.txt for citation guidance.
◌ Single Source
Organon, The New Jersey-based drugmaker focused on women's health that was spun off by Merck jumped 24%.
Key facts
- Barclays cut its 12-month price target to $1,950 from $2,400 while keeping an overweight rating, according to FactSet
- Texas Pacific Land -- The Texas landowner gained 9%, a day after the death of Horizon Kinetics CEO Murray Stahl sent shares tumbling nearly 16%
- Revenue was up 35% year-over-year, totaling 1.13 trillion new Taiwan dollars, or $35.6 billion
- Palo Alto Networks was off more than 6%, Zscaler declined 3%, while CrowdStrike tumbled 4%
Summary
Here are the names making headlines in midday trading. Broadcom and AMD each added 4% and 3%, respectively. The VanEck Semiconductor ETF (SMH) rose 1.7%. Barclays cut its 12-month price target to $1,950 from $2,400 while keeping an overweight rating, according to FactSet.